Showing 121 - 140 results of 791 for search 'azuki~', query time: 3.44s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124

    Nano-Pd/Chitosan Composite: An Extremely Effective Catalyst to the Synthesis of Pyrazolyl Analogues through Suzuki–Miyaura Cross-Coupling Reactions in an Aqueous Medium by M. Senthilkumar, P. Manisankar, R. Pandimurugan, P. A. Vivekanand, Govindasami Periyasami, S. Harikumar, Perumal Karthikeyan, Mostafizur Rahaman, Santosh Khanal

    Published 2023-01-01
    “…Substituted pyrazolyl derivatives were synthesized through Suzuki cross coupling of aromatic boronic acid with heterocyclic halide using newly synthesized nano-Pd/chitosan catalyst by the water-mediated green synthesis methodology. …”
    Get full text
    Article
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130
  11. 131

    Clinical isolates of Candida auris with enhanced adherence and biofilm formation due to genomic amplification of ALS4. by Jian Bing, Zhangyue Guan, Tianhong Zheng, Zhijie Zhang, Shuru Fan, Craig L Ennis, Clarissa J Nobile, Guanghua Huang

    Published 2023-03-01
    “…Candida auris is an emerging multidrug-resistant fungal pathogen and a new global threat to human health. …”
    Get full text
    Article
  12. 132

    La heroína y la bruja en “Muñeca vestida de azul”, de Delfina Careaga by Ramón Gutiérrez-Villavicencio

    Published 2016-01-01
    “…Se hizo énfasis en la presencia del augurio como motor de los acontecimientos en la historia, así como en el simbolismo de las muñecas y el color azul. Finalmente, se dio cuenta de la importancia de la evocación y la confesión como estrategias narrativas.…”
    Get full text
    Article
  13. 133
  14. 134
  15. 135

    Absolutely on Music / by Murakami, Haruki

    Published 2016
    View in OPAC
    Book
  16. 136

    Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial by Keiichi Fukuda, Satoshi Yasuda, Hiroyuki Tsutsui, Toyoaki Murohara, Kohtaro Abe, Koichiro Tatsumi, Junji Kishimoto, Yu Taniguchi, Yuichi Tamura, Koji Todaka, Shun Minatsuki, Kazuya Hosokawa, Yuko Kobayakawa, Takumi Inami, Nobutaka Ikeda

    Published 2022-07-01
    “…The present trial seeks to evaluate whether edoxaban is non-inferior to warfarin in preventing worsening of CTEPH.Methods and analysis The KABUKI trial (is an investigator-initiated, multicentre, phase 3, randomised, single-blind, parallel-group, warfarin-controlled, non-inferiority trial to evaluate the efficacy and safety of edoxaban versus warfarin (vitamin K Antagonist) in subjects with chronic thromBoembolic pUlmonary hypertension taking warfarin (vitamin K antagonIst) at baseline) is designed to prove the non-inferiority of edoxaban to warfarin in terms of efficacy and safety in patients with CTEPH.Ethics and dissemination This study is approved by the Institutional Review Board of each participating institution. …”
    Get full text
    Article
  17. 137
  18. 138
  19. 139
  20. 140